Details for New Drug Application (NDA): 202467
✉ Email this page to a colleague
The generic ingredient in PIOGLITAZONE HYDROCHLORIDE is metformin hydrochloride; pioglitazone hydrochloride. There are forty-nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the metformin hydrochloride; pioglitazone hydrochloride profile page.
Summary for 202467
| Tradename: | PIOGLITAZONE HYDROCHLORIDE |
| Applicant: | Macleods Pharms Ltd |
| Ingredient: | pioglitazone hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 202467
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 202467 | ANDA | NorthStar RxLLC | 16714-645 | 16714-645-01 | 30 TABLET in 1 BOTTLE (16714-645-01) |
| PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 202467 | ANDA | NorthStar RxLLC | 16714-645 | 16714-645-02 | 90 TABLET in 1 BOTTLE (16714-645-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 15MG BASE | ||||
| Approval Date: | Feb 6, 2013 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 30MG BASE | ||||
| Approval Date: | Feb 6, 2013 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 45MG BASE | ||||
| Approval Date: | Feb 6, 2013 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
